Cyclerion shareholders elect all six director nominees at annual meeting

Cyclerion Therapeutics, Inc.

All six director nominees elected with >1.3M votes for each; broker non-votes 743,285.
Ratification of Ernst & Young as auditor approved with 2,072,684 for, 57,547 against.
Advisory say-on-pay passed with 1,312,697 for, 78,221 against, 6,203 abstain.
Shareholders selected one-year frequency for future advisory votes on executive compensation.
Proposal to adjourn meeting if needed also approved with 2,036,703 for.

item 5.07item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.